Are InvAscent, MO Alts beating the benchmark in partial exit from pharma company?
VCCircleVCCircle
LoginSubscribe
INDMEA
Advertisement
  • Home
  • Healthcare
  • Are InvAscent, MO Alts beating the benchmark in partial exit from pharma company?

Are InvAscent, MO Alts beating the benchmark in partial exit from pharma company?

Pro
Are InvAscent, MO Alts beating the benchmark in partial exit from pharma company?
Logos of InvAscent and Motilal Oswal

Mid-market private equity firms InvAscent and Motilal Oswal Alternates are partially exiting a pharmaceutical company in......

New to VCCircle.com?

Subscribe to VCCircle PRO and get privileged access to exclusive curated articles!

Already a VCCircle PRO member? Click here to log in.
Advertisement

Related Articles

Premium
Diagnostics firm Usmanpura Imaging taps family office for west India expansion

Healthcare

Diagnostics firm Usmanpura Imaging taps family office for west India expansion

Premium
Homegrown PE firms join global rivals in race for stake in Agappe Diagnostics

Healthcare

Homegrown PE firms join global rivals in race for stake in Agappe Diagnostics

Manipal Health to buy Kinder Women's Hospital; Dunzo co-founder joins Superhealth

Healthcare

Manipal Health to buy Kinder Women's Hospital; Dunzo co-founder joins Superhealth

Tata Capital Healthcare Fund, Swiss impact investor bet on Tenet Diagnostics

Healthcare

Tata Capital Healthcare Fund, Swiss impact investor bet on Tenet Diagnostics

Premium
Lightrock inks partial exit from a nearly seven-year-old healthcare bet

Healthcare

Lightrock inks partial exit from a nearly seven-year-old healthcare bet

Pro
How are TPG and Temasek faring in latest India exit move?

Healthcare

How are TPG and Temasek faring in latest India exit move?

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW